Role of Lipid-Lowering Pharmacotherapy in Children

Author： Tonstad S.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.2, Iss.1, 2000-01, pp. : 11-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperlipidaemia in Paediatric Patients: The Role of Lipid-Lowering Therapy in Clinical Practice

By Wierzbicki Anthony S.  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Preventing Cardiovascular Outcome in Patients with Renal Impairment: Is There a Role for Lipid-Lowering Therapy?

By Holdaas Hallvard  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 255-269

Adis International

Access to resources Recommend Favorite

The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3094-3106

Bentham Science Publishers

Access to resources Recommend Favorite

New lipid-lowering agents

By Wierzbicki Anthony S  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of lipid-lowering therapies

By Hu Miao   Tomlinson Brian  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 981-995

Future Medicine

Access to resources Recommend Favorite